Multicenter phase II trial of temsirolimus (TEM) and bevacizumab (BEV) in pancreatic neuroendocrine tumor (PNET) Meeting Abstract
| Authors: | Hobday, T. J.; Qin, R.; Moore, M. J.; Reidy, D. L.; Strosberg, J. R.; Kindler, H. L.; Shah, M. H.; Lenz, H. J.; Kaubisch, A.; Chen, H. X.; Erlichman, C. |
| Abstract Title: | Multicenter phase II trial of temsirolimus (TEM) and bevacizumab (BEV) in pancreatic neuroendocrine tumor (PNET) |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419601406 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.4032 |
| Notes: | Meeting Abstract: 4032 -- Source: Wos |
